These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 33770206)
1. Lysosomal escaped protein nanocarriers for nuclear-targeted siRNA delivery. Cao X; Shang X; Guo Y; Zheng X; Li W; Wu D; Sun L; Mu S; Guo C Anal Bioanal Chem; 2021 May; 413(13):3493-3499. PubMed ID: 33770206 [TBL] [Abstract][Full Text] [Related]
2. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy. Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792 [TBL] [Abstract][Full Text] [Related]
3. Visible light-switched cytosol release of siRNA by amphiphilic fullerene derivative to enhance RNAi efficacy in vitro and in vivo. Wang J; Xie L; Wang T; Wu F; Meng J; Liu J; Xu H Acta Biomater; 2017 Sep; 59():158-169. PubMed ID: 28511875 [TBL] [Abstract][Full Text] [Related]
4. Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells. Joris F; De Backer L; Van de Vyver T; Bastiancich C; De Smedt SC; Raemdonck K J Control Release; 2018 Jan; 269():266-276. PubMed ID: 29146245 [TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery. Chen G; Wang Y; Xie R; Gong S J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516 [TBL] [Abstract][Full Text] [Related]
6. Engineered Hsp Protein Nanocages for siRNA Delivery. Guan X; Chang Y; Sun J; Song J; Xie Y Macromol Biosci; 2018 May; 18(5):e1800013. PubMed ID: 29665276 [TBL] [Abstract][Full Text] [Related]
7. Bioengineered Protein Nanocage by Small Heat Shock Proteins Delivering mTERT siRNA for Enhanced Colorectal Cancer Suppression. Wang H; Liu N; Yang F; Hu N; Wang M; Cui M; Bruns N; Guan X ACS Appl Bio Mater; 2022 Mar; 5(3):1330-1340. PubMed ID: 35234441 [TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and siRNA by a simplified platform with oligodeoxynucleotides as a drug carrier. Liu T; Wang M; Wang T; Yao Y; Zhang N Colloids Surf B Biointerfaces; 2015 Feb; 126():531-40. PubMed ID: 25618822 [TBL] [Abstract][Full Text] [Related]
10. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735 [TBL] [Abstract][Full Text] [Related]
11. Chitosan Nanoparticles for Nuclear Targeting: The Effect of Nanoparticle Size and Nuclear Localization Sequence Density. Tammam SN; Azzazy HM; Breitinger HG; Lamprecht A Mol Pharm; 2015 Dec; 12(12):4277-89. PubMed ID: 26465978 [TBL] [Abstract][Full Text] [Related]
12. Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus. Canine BF; Wang Y; Ouyang W; Hatefi A J Control Release; 2011 Apr; 151(1):95-101. PubMed ID: 21192992 [TBL] [Abstract][Full Text] [Related]
13. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA. Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128 [TBL] [Abstract][Full Text] [Related]
14. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System. Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841 [TBL] [Abstract][Full Text] [Related]
15. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420 [TBL] [Abstract][Full Text] [Related]
16. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery. Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914 [TBL] [Abstract][Full Text] [Related]
17. Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin. Cao Y; Huang HY; Chen LQ; Du HH; Cui JH; Zhang LW; Lee BJ; Cao QR ACS Appl Mater Interfaces; 2019 Mar; 11(10):9763-9776. PubMed ID: 30776886 [TBL] [Abstract][Full Text] [Related]
18. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance. Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564 [TBL] [Abstract][Full Text] [Related]
19. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells. Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693 [TBL] [Abstract][Full Text] [Related]
20. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery. Wang XL; Xu R; Lu ZR J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]